<DOC>
	<DOCNO>NCT00092521</DOCNO>
	<brief_summary>The primary purpose study determine GARDASIL ( V501 ) four component able prevent cervical cancer , cervical dysplasia , include Cervical Intraepithelial Neoplasia ( CIN ) ( Any Grade ) Adenocarcinoma In Situ ( AIS ) , genital wart .</brief_summary>
	<brief_title>Cervical Intraepithelial Neoplasm ( CIN ) -Warts Efficacy Trial Women ( Gardasil ) ( V501-013 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female intact uterus lifetime history 04 sexual partner Prior Human Papillomavirus ( HPV ) vaccination Prior abnormal pap History genital wart</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>